A necessidade de metodologias adequadas para análise de fármacos e seus metabólitos em matrizes biológicas complexas levaram a um crescente interesse no desenvolvimento de novas técnicas de preparação de amostras, particularmente as técnicas de microextração, por serem altamente seletivas e requererem o consumo mínimo de solventes orgânicos. Aliado a esses avanços, o emprego de modernas e eficientes tecnologias analíticas, como a eletroforese capilar (CE) e a cromatografia líquida de alta eficiência acoplada à espectrometria de massas (LC-MS-MS), tem resultado em um considerável avanço em qualidade nas metodologias analíticas disponíveis para bioanálises. Dentro desse cenário, destaca-se a utilização dessas técnicas para o desenvolvimento de metodologias enantiosseletivas, permitindo quantificar os enantiômeros de fármacos administrados como racematos. Sendo assim, propusemos o desenvolvimento e a validação de metodologias enantiosseletivas para a análise dos enantiômeros da mirtazapina (MRT) e de seus principais metabólitos em plasma e urina, utilizando a CE e a LC-MS-MS. Para a preparação das amostras foram empregadas a microextração em fase sólida (SPME) e a microextração em fase líquida (LPME). No primeiro método desenvolvido, a LPME foi utilizada para extrair os analitos das amostras de plasma (1 mL), previamente diluídas, alcalinizadas com 3,0 mL de uma solução tampão fosfato 0,5 mol L-1 (pH 8) e adicionadas de 15% (m/v) de cloreto de sódio. Éter n-hexílico e uma solução de ácido acético 0,01 moL L-1 foram utilizados como solvente extrator e fase aceptora, respectivamente. As análises cromatográficas foram feitas em uma coluna Chiralpak AD-RH, empregando acetonitrila:metanol:etanol (98:1:1, v/v/v) mais 0,2% de dietilamina como fase móvel, na vazão de 1 mL min-1. A detecção dos analitos foi conduzida por LC-MS-MS usando um analisador triplo-quadrupolo e ionização por eletrospray positivo. Nessas condições, foram obtidas recuperações de 18,3 a 45,5%, resposta linear na faixa de concentração de 1,25-125 ng mL-1 e limite de quantificação (LQ) de 1,25 ng mL-1 para todos os enantiômeros avaliados. Posteriormente, a CE e a LPME foram utilizadas para a análise da MRT e seus principais metabólitos em urina. Antes da extração, amostras de urina (1 mL) foram submetidas a hidrólise enzimática a 37 ºC por 16 horas. Então, a enzima foi precipitada com ácido tricloroacético, o pH foi ajustado para 8 com uma solução tampão fosfato 0,5 mol L-1 (pH 11) e 10% de NaCl também foi adicionado. Em seguida as amostras foram submetidas a extração de forma similar aquela realizada para as amostras de plasma. As análises eletroforéticas foram obtidas em uma solução tampão fosfato 50 mmol L-1 (pH 2,5) contendo 0,55% (m/v) de carboximetil-b-ciclodextrina (CM-b-CD). O método foi linear na faixa de concentração de 62,5-2500 ng mL-1 para cada enantiômero da MRT e 8-hidroximirtazapina (8-OHM) e 62,5-1250 ng mL-1 para cada enantiômero da desmetilmirtazapina (DMR). O LQ foi 62,5 ng mL-1 para todos os enantiômeros. A SPME também foi utilizada no desenvolvimento de um método para a determinação simultânea do fármaco e seus metabólitos em urina usando CE e LC-MS-MS. Os analitos de interesse foram transferidos da solução aquosa hidrolisada para uma fibra de polidimetilsiloxano-divinilbenzeno (PMDS-DVB) e então foram desorvidos em metanol. As recuperações médias foram de 12 % para os enantiômeros da MRT, 3,8 % para a DMR e 0,72 % para a 8-OHM. O método foi linear na faixa de concentração de 62,5-2500 ng mL-1 com adequado LQ (62,5 ng mL-1) para todos os enantiômeros. A precisão e exatidão foram menores que 15% para todos os métodos desenvolvidos. Além disso, os métodos foram adequadamente aplicados em estudos preliminares de determinação dos enantiômeros da MRT, 8-OHM e DMR em amostras de plasma e urina obtidos após a administração oral de uma dose única de rac-MRT a voluntários sadios. / The need for appropriate methodology for the analysis of drugs and their metabolites in complex biological matrices led to a growing interest in developing new techniques for sample preparation, particularly microextraction techniques because they are highly selective and require a minimum consumption of organic solvents. Allied to these developments, the employment of modern and efficient analytical technologies, such as capillary electrophoresis (CE) and high-performance liquid chromatography coupled to mass spectrometry (LC-MS-MS), has resulted in a considerable improvement in quality in the analytical methodologies available for bioanalysis. In this context, it is worth to mention the use of such techniques to develop enantioselective methodologies, allowing the quantification of the enantiomers of drugs administered as racemates. Therefore, we proposed the development and validation of enantioselective methodologies for the analysis of the enantiomers of mirtazapine (MRT) and of its main metabolites in plasma and urine, using the CE and LC-MS-MS. Solid phase microextraction (SPME) and liquid phase microextraction (LPME) were used for sample preparation. In the first method, LPME was used to extract the analytes from plasma samples (1 ml), previously diluted, alkalinized with 3.0 mL 0.5 mol L-1 pH 8 phosphate buffer solution and supplemented with 15% (w/v) sodium chloride. N-hexyl ether and 0.01 mol L-1 acetic acid solution were used as solvent extractor and acceptor phase, respectively. The analyses were carried out on a CHIRALPAK AD-RH column and acetonitrile: methanol: ethanol (98:1:1, v / v / v) plus 0.2% of diethylamine was used as mobile phase, at a flow rate of 1 mL min-1. The detection was performed by LC-MS-MS equipped with a triple-quadrupole analyzer and ionization by eletrospray positive. Under these conditions, recoveries were from 18.3 to 45.5%; linear response over the 1,25-125 ng ml-1 concentration range and limit of quantification (LOQ) of 1.25 ng ml-1 for all enantiomers evaluated were obtained. CE and LPME were also used for the analysis of MRT and its main metabolites in urine. Before the extraction, urine samples (1 mL) were submitted to enzymatic hydrolysis at 37 ºC for 16 hours, the enzyme was precipitated with trichloroacetic acid, the pH was adjusted to 8 with 0.5 mol L-1 phosphate buffer solution (pH 11) and 10% (w/v) sodium chloride was further added. Then, the LPME extraction was performed according to the procedure previously developed. The electrophoretic analyses were carried out in 50 mmol L-1 phosphate buffer solution (pH 2.5) containing 0.55% (w/v) carboxymethyl-b-cyclodextrin (CM-b-CD). The method was linear over the concentration range of 62.5-2500 ng mL-1 for each MRT and 8-OHM enantiomer and 62.5-1250 ng mL-1 for each DMR enantiomer. The quantification limit (LOQ) was 62.5 ng mL-1 for all the enantiomers. A SPME method was also developed for the simultaneous enantioselective determination of MRT and its metabolites in urine using CE and LC-MS-MS. The target analytes were transferred from the hydrolyzed aqueous solution to the polydimetylsiloxane-divinylbenzene (PMDS-DVB) fiber coating and then desorbed in methanol. The means recoveries were 12 % for the enantiomers of MRT, 3.8 % for DMR and 0.72 % for 8-OHM. The method was linear over the concentration range of 62.5-2500 ng mL-1 with suitable LOQ (62.5 ng mL-1) for all the enantiomers. The precision and accuracy were lower than 15% for all developed methods. Moreover, the methods were successfully employed for the determination of MRT, 8-OHM and DMR enantiomers in plasma and urine samples obtained after oral administration of a single dose of rac-MRT to healthy volunteers.

A necessidade de metodologias adequadas para análise de fármacos e seus metabólitos em matrizes biológicas complexas levaram a um crescente interesse no desenvolvimento de novas técnicas de preparação de amostras, particularmente as técnicas de microextração, por serem altamente seletivas e requererem o consumo mínimo de solventes orgânicos. Aliado a esses avanços, o emprego de modernas e eficientes tecnologias analíticas, como a eletroforese capilar (CE) e a cromatografia líquida de alta eficiência acoplada à espectrometria de massas (LC-MS-MS), tem resultado em um considerável avanço em qualidade nas metodologias analíticas disponíveis para bioanálises. Dentro desse cenário, destaca-se a utilização dessas técnicas para o desenvolvimento de metodologias enantiosseletivas, permitindo quantificar os enantiômeros de fármacos administrados como racematos. Sendo assim, propusemos o desenvolvimento e a validação de metodologias enantiosseletivas para a análise dos enantiômeros da mirtazapina (MRT) e de seus principais metabólitos em plasma e urina, utilizando a CE e a LC-MS-MS. Para a preparação das amostras foram empregadas a microextração em fase sólida (SPME) e a microextração em fase líquida (LPME). No primeiro método desenvolvido, a LPME foi utilizada para extrair os analitos das amostras de plasma (1 mL), previamente diluídas, alcalinizadas com 3,0 mL de uma solução tampão fosfato 0,5 mol L-1 (pH 8) e adicionadas de 15% (m/v) de cloreto de sódio. Éter n-hexílico e uma solução de ácido acético 0,01 moL L-1 foram utilizados como solvente extrator e fase aceptora, respectivamente. As análises cromatográficas foram feitas em uma coluna Chiralpak AD-RH, empregando acetonitrila:metanol:etanol (98:1:1, v/v/v) mais 0,2% de dietilamina como fase móvel, na vazão de 1 mL min-1. A detecção dos analitos foi conduzida por LC-MS-MS usando um analisador triplo-quadrupolo e ionização por eletrospray positivo. Nessas condições, foram obtidas recuperações de 18,3 a 45,5%, resposta linear na faixa de concentração de 1,25-125 ng mL-1 e limite de quantificação (LQ) de 1,25 ng mL-1 para todos os enantiômeros avaliados. Posteriormente, a CE e a LPME foram utilizadas para a análise da MRT e seus principais metabólitos em urina. Antes da extração, amostras de urina (1 mL) foram submetidas a hidrólise enzimática a 37 ºC por 16 horas. Então, a enzima foi precipitada com ácido tricloroacético, o pH foi ajustado para 8 com uma solução tampão fosfato 0,5 mol L-1 (pH 11) e 10% de NaCl também foi adicionado. Em seguida as amostras foram submetidas a extração de forma similar aquela realizada para as amostras de plasma. As análises eletroforéticas foram obtidas em uma solução tampão fosfato 50 mmol L-1 (pH 2,5) contendo 0,55% (m/v) de carboximetil-b-ciclodextrina (CM-b-CD). O método foi linear na faixa de concentração de 62,5-2500 ng mL-1 para cada enantiômero da MRT e 8-hidroximirtazapina (8-OHM) e 62,5-1250 ng mL-1 para cada enantiômero da desmetilmirtazapina (DMR). O LQ foi 62,5 ng mL-1 para todos os enantiômeros. A SPME também foi utilizada no desenvolvimento de um método para a determinação simultânea do fármaco e seus metabólitos em urina usando CE e LC-MS-MS. Os analitos de interesse foram transferidos da solução aquosa hidrolisada para uma fibra de polidimetilsiloxano-divinilbenzeno (PMDS-DVB) e então foram desorvidos em metanol. As recuperações médias foram de 12 % para os enantiômeros da MRT, 3,8 % para a DMR e 0,72 % para a 8-OHM. O método foi linear na faixa de concentração de 62,5-2500 ng mL-1 com adequado LQ (62,5 ng mL-1) para todos os enantiômeros. A precisão e exatidão foram menores que 15% para todos os métodos desenvolvidos. Além disso, os métodos foram adequadamente aplicados em estudos preliminares de determinação dos enantiômeros da MRT, 8-OHM e DMR em amostras de plasma e urina obtidos após a administração oral de uma dose única de rac-MRT a voluntários sadios. / The need for appropriate methodology for the analysis of drugs and their metabolites in complex biological matrices led to a growing interest in developing new techniques for sample preparation, particularly microextraction techniques because they are highly selective and require a minimum consumption of organic solvents. Allied to these developments, the employment of modern and efficient analytical technologies, such as capillary electrophoresis (CE) and high-performance liquid chromatography coupled to mass spectrometry (LC-MS-MS), has resulted in a considerable improvement in quality in the analytical methodologies available for bioanalysis. In this context, it is worth to mention the use of such techniques to develop enantioselective methodologies, allowing the quantification of the enantiomers of drugs administered as racemates. Therefore, we proposed the development and validation of enantioselective methodologies for the analysis of the enantiomers of mirtazapine (MRT) and of its main metabolites in plasma and urine, using the CE and LC-MS-MS. Solid phase microextraction (SPME) and liquid phase microextraction (LPME) were used for sample preparation. In the first method, LPME was used to extract the analytes from plasma samples (1 ml), previously diluted, alkalinized with 3.0 mL 0.5 mol L-1 pH 8 phosphate buffer solution and supplemented with 15% (w/v) sodium chloride. N-hexyl ether and 0.01 mol L-1 acetic acid solution were used as solvent extractor and acceptor phase, respectively. The analyses were carried out on a CHIRALPAK AD-RH column and acetonitrile: methanol: ethanol (98:1:1, v / v / v) plus 0.2% of diethylamine was used as mobile phase, at a flow rate of 1 mL min-1. The detection was performed by LC-MS-MS equipped with a triple-quadrupole analyzer and ionization by eletrospray positive. Under these conditions, recoveries were from 18.3 to 45.5%; linear response over the 1,25-125 ng ml-1 concentration range and limit of quantification (LOQ) of 1.25 ng ml-1 for all enantiomers evaluated were obtained. CE and LPME were also used for the analysis of MRT and its main metabolites in urine. Before the extraction, urine samples (1 mL) were submitted to enzymatic hydrolysis at 37 ºC for 16 hours, the enzyme was precipitated with trichloroacetic acid, the pH was adjusted to 8 with 0.5 mol L-1 phosphate buffer solution (pH 11) and 10% (w/v) sodium chloride was further added. Then, the LPME extraction was performed according to the procedure previously developed. The electrophoretic analyses were carried out in 50 mmol L-1 phosphate buffer solution (pH 2.5) containing 0.55% (w/v) carboxymethyl-b-cyclodextrin (CM-b-CD). The method was linear over the concentration range of 62.5-2500 ng mL-1 for each MRT and 8-OHM enantiomer and 62.5-1250 ng mL-1 for each DMR enantiomer. The quantification limit (LOQ) was 62.5 ng mL-1 for all the enantiomers. A SPME method was also developed for the simultaneous enantioselective determination of MRT and its metabolites in urine using CE and LC-MS-MS. The target analytes were transferred from the hydrolyzed aqueous solution to the polydimetylsiloxane-divinylbenzene (PMDS-DVB) fiber coating and then desorbed in methanol. The means recoveries were 12 % for the enantiomers of MRT, 3.8 % for DMR and 0.72 % for 8-OHM. The method was linear over the concentration range of 62.5-2500 ng mL-1 with suitable LOQ (62.5 ng mL-1) for all the enantiomers. The precision and accuracy were lower than 15% for all developed methods. Moreover, the methods were successfully employed for the determination of MRT, 8-OHM and DMR enantiomers in plasma and urine samples obtained after oral administration of a single dose of rac-MRT to healthy volunteers.

The thesis entitled "Pushing the Limits of NMR Sensitivity and Chiral Analysis: Design of New NMR Methods and Bio-molecular Tools" consists of six chapters. The research work reported in this thesis is focused on the development of novel chemical and NMR methodological approaches for enantiomeric analysis and mea- surement of residual dipolar couplings (RDCs), and the development of sensitivity enhanced slice selective NMR experiments for obtaining pure shift 1H spectra and the measurement of scalar couplings. The thesis is divided into two parts. The Part I comprises chapters 2-4, where the enantiomeric analysis is discussed, which includes newly developed chiral reagents, two new weak chiral aligning media and design of novel NMR techniques. Part II comprises chapters 5 and 6, which discusses new sensitivity enhanced slice selective NMR techniques. Chapter 1 gives a general introduction to NMR and the problems investigated in the remaining chapters of the thesis. The chapter starts with a brief discussion on the introduction, advancements and general applications of NMR, discussion is also given on the NMR approaches for enantiomeric analysis both in isotropic and anisotropic phases and the measurement of RDCs, including the benefits and limitations associated with each approach. The chapter sets the tone by discussing limitations of the existed NMR enantiomeric approaches and slice-selective techniques, and builds the bridge for the rest of the chapters by addressing these limitations. The chapter also introduces slice selective experiments, their benefits over other conventional methods and limitations. Additional introductory notes are also given on some related concepts. Part I : NMR Chiral analysis and RDCs measurements Chapter 2 discusses chiral sensing properties of RNA nucleosides and their utility as chiral derivatizing agents for the enantio-discrimination of 1o-amines using one dimensional 1H NMR. A three component protocol has been proposed for the complexation of nucleosides with amines, which is rapid, economical and provides maximum diastereomeric conversion. The chiral differentiating ability of nucleosides are examined for different amines based on the 1H NMR chemical shift differences between the diastereomers (∆δ R, S ). Enantiomeric differentiation has been observed at multiple chemically distinct proton sites. It is observed that adenosine and guanosine exhibit large chiral differentiation (∆δ R, S ) due to the presence of a purine ring. The comparison of the diastereomeric excess (de) measured by NMR with those of the gravimetrically prepared ratios are in excellent agreement with each other confirming the robustness of these RNA nucleosides in discriminating primary amines. Chapter 3 establishes the smooth connectivity with the chapter 2 by discussing the limitations of the enantiomeric discrimination using NMR in isotropic solutions. This chapter discusses two new water compatible aligning media that were developed based on self-assembling strategy of small bio-molecules. The self-assembled folic acid, and the binary mixture of 50-GMP and guanosine are introduced as two novel weak aligning media. The properties of these low ordered media have been systematically studied for their easy preparation, physical parameter dependent tunability of their degree of alignment, mesosphere sustainability over a broad range of temperature and the concentration of the ingredients, and the phase reproducibility. The applications of both these new media are demonstrated for chiral and pro-chiral discrimination and also for the measurement of RDCs. Both these liquid crystalline media could be tuned to very low degree of alignment (order parameter of the order of 10−4), which provides simple first order spectra of molecules aligned in them, the analysis provide order dependent NMR spectral parameters. The 50-GMP:guanosine orienting medium can be prepared in less than 1 hour, and has been demonstrated to be an ideal medium for the determination of RDCs that are used as restraints in the structure calculations of small molecules. Chapter 4 describes 1H NMR spectral complexity in isotropic and anisotropic phases and its consequences on enantiomeric analysis. In circumventing such problems, new NMR techniques have been developed and the spin dynamics involved in the designed sequences are discussed. The newly developed 2D 1H NMR experimental method termed as RES-TOCSY, and its applicability for resolving R and S enantiomeric or diastereomeric peaks of all the coupled proton spins in isotropic phase is discussed. The utility of the developed method is demonstrated in diverse situations, such as, for suppressing impurities peaks, resolving the severely overlapped peaks and unraveling the peaks masked due to severe line broadening when metal complexes are used as chiral auxiliaries. The advantages and limitations of the method over other methods available in the literature are discussed and the significant advantage of the present method is illustrated by spectral comparison with J-resolved experiment. The appli- cation of the method for the accurate measurement of enantiomeric excess has also been demonstrated. The chapter also introduces another NMR experimental technique developed for resolving enantiomeric peaks and complete unraveling of R and S spectra in anisotropic phase. The developed 2D NMR method is cited in the literature as CH-RES-TOCSY. In addition to spectroscopic visualization of R and S spectra, the method also yields C-H RDCs. The applicability of the new experiment has been demonstrated on a chosen example. The wide utility of the method has also been demonstrated for the assignment of symmetric cis- and trans- isomers. Part II : Sensitivity Enhancement of Slice selective NMR Experiments Chapter 5 describes applications of slice selective NMR experiments over conven tional NMR methods and their limitations as far as the sensitivity of signal detection is concerned, especially in low concentrated samples. The chapter introduces the implementation of Acceleration by Sharing Adjacent Polarization (ASAP) technique in slice selective experiments. It is convincingly demonstrated that ASAP helps in reducing inter scan relaxation delay and consequently permits acquisition of more number of scans in a given time, resulting in the gain in signal enhancement by a factor of two. The pulse sequences have been suitably designed for obtaining the pure shift 1H spectra and in G-SERF experiment for the measurement of 1H-1H couplings, both with significantly enhanced signal intensities. Chapter 6 describes new sensitivity enhanced slice selective NMR methods for mea- surement of scalar couplings. A new experiment has been developed which is named as Quick G-SERF (QG-SERF). It is a 1D NMR slice selective method developed based on real time spin manipulation technique. The method gives multiple scalar couplings of a selected spin with simplified multiplets, which is analogous to the 2D G-SERF but with considerable saving in instrument time by 1-2 orders of magnitude. The rapidness of the experiment arises due to reduced dimensionality. The spin dynamics involved in the pulse sequence and its working principle have been described. The application of the method is illustrated for the measurement of 1H-1H couplings. The sequence has been further improved to obtain the heteronuclear couplings between two abundant spins in an orchestrated manner and has been demonstrated for measurement of 1H-19F couplings. This sequence cited as HF-QG-SERF has been implemented on the molecules containing number of chemically non-equivalent fluorine atoms.

No description available.

An optimized method for the chiral resolution of enantiomers of amino acids in bacterial supernatants is reported. This LC-MS/MS method is performed using a chiral Teichoplanin LC column and does not require sample clean up or chemical derivitization. This method allows for the determination of the relative amounts of the D and L enantiomers of 20 proteinogenic amino acids. The detection limits and response factors for the 20 amino acids were determined. Calibrations over three orders of magnitude showed least squares coefficient values (R^2) greater than 0.996 for eighty percent of the amino acids and greater than 0.992 for the remainder. The amino acids and their enantiomers were identified based on their retention times and their unique Multiple Reaction Monitoring (MRM) transitions for each amino acid. L-Aspartic acid-2,3,3-d3 was used as the internal standard. Cultures of Sinorhizobium meliloti (a nitrogen-fixing soil bacterium) were grown on minimal media; thus, all amino acids were biosynthesized by the bacterium. After centrifugation, supernatants were freeze dried, reconstituted in a small volume of methanol/water with internal standard and injected onto the LC column. The amino acids detected in the bacterial supernatant and the concentrations of the enantiomers were reported as the L and D isomers respectively: arginine [L, 12.6 ± 3.1 μg/L; D, 10.1 ± 3.2 μg/L], serine [L, 7.2 ± 1.16 μg/L; D, n.d.], threonine [L, n.d.; D, 11.2 ± 2.7 μg/L] and valine [L, 15.5 ± 4.3 μg/L; D, 11.3 ± 3.7 μg/L], where the term n.d. means below detection limit. The limits for detection for all amino acids ranged from 1.3 μg/L - 5.1 μg/L. In media with no added phosphate, the amino acid profiles changed somewhat under these stress conditions. Arginine was no longer detected while alanine and proline were now observed; the concentrations of the amino acids were: alanine [L, 7.7 ± 1.2 μg/L; D, 13.4 ± 2.5 μg/L], proline [L, n.d.; D, 8.63 ± 1.3 μg/L], serine [L, 7.6 ± 1.2 μg/L; D, n.d.], threonine [L, n.d.; D, 10.2 ± 3.2 μg/L] and valine [L, 11.6 ± 2.3 μg/L; D, 10.1 ± 3.1 μg/L]. These data represent the mean values of three independent bacterial growth experiments conducted over a 3 month period; the data came from the analysis of five separate aliquots from each growth experiment. The percent standard deviation for these data ranged from 15% to 33% and averaged 24%. Under both the normal and stressed growth conditions of S. meliloti produced the L enantiomer of serine, the D enantiomer of threonine and racemic valine. While racemic arginine was observed under normal growth conditions, levels were below detection under stressed conditions; under stress conditions only the D enantiomer of proline was observed while alanine was found in 1:2, L:D ratio. / Thesis / Master of Science (MSc)

Atualmente, as doenças cardiovasculares constituem as principais causas de morte no Brasil e no mundo. As estatinas são consideradas os agentes mais efetivos e mais bem tolerados para o tratamento do aumento excessivo dos níveis de colesterol no sangue, ou hipercolesterolemia. A fluvastatina (FLV), um fármaco hipolipêmico, de segunda geração, pertencente à classe das estatinas, e é comercializada como mistura racêmica, ou seja, uma mistura equimolar da (+)-3R, 5S-FLV e (-)-3S, 5R-FLV. Além disso, é descrito na literatura que o enantiômero (+)- 3R, 5S- FLV possui atividade cerca de trinta vezes maior do que seu antípoda, o que justifica a importância e necessidade de métodos para análise enantiosseletiva de fármacos que possuam um ou mais centros de assimetria. Assim, este trabalho teve como objetivo a extração dos enantiômeros da FLV de matriz biológica (plasma) utilizando uma técnica de eletromigração em capilar, a cromatografia eletrocinética (EKC). A análise da FLV por cromatografia eletrocinética empregou como técnica de concentração online o stacking por injeção de grande volume, em um capilar de sílica fundida não revestido, de 50,0 cm de comprimento efetivo e 75 ?m de diâmetro interno, solução tampão tetraborato de sódio 50 mmol L-1, pH 9,5; adicionado de 20 mmol L-1 de 2-hidroxipropil-?-ciclodextrina como eletrólito de corrida, tensão de +25 kV, temperatura de 15 °C, injeção hidrodinâmica (0,5 psi por 30 segundos) e detecção em 300 nm. A separação dos enantiômeros foi obtida com valores de resolução de 3,0 e eficiência de 255840 e 150056, e tempos de migração de 7,2 e 7,4 minutos para a (+)-3R, 5S- FLV e (-)-3S, 5R- FLV, respectivamente. O procedimento de preparo de amostra foi baseado na extração em fase sólido-líquida (SLE), com a adição de 0,5 mL de solução tampão fosfato de sódio 0,1 mol L-1 pH 7,0 em 0,5 mL de plasma, previamente fortificado com padrão de FLV. A amostra foi aplicada na coluna e depois de 15 minutos, a FLV foi eluída com 4 mL de éter etílico. O método analítico foi validado avaliando os parâmetros seletividade, linearidade, precisão e exatidão inter e intra-dia, limite de quantificação, carry-over, efeito matriz, integridade da diluição e estudos de estabilidade. Além disso, foi realizado o estudo de racemização. Os resultados apresentaram linearidade na faixa de concentração plasmática de 250 a 725 ng mL-1 para cada enantiômero, sendo o limite de quantificação a concentração de 250 ng mL-1. Os estudos de precisão e exatidão apresentaram valores aceitáveis, com variação menor do que 15%. Além disso, não foi observado efeito carry-over e as amostras foram estáveis quando submetidas a ciclos de congelamento e descongelamento, estabilidade de curta e longa duração, pós-processamento e não foi observada racemização dos enantiômeros. Em relação ao efeito matriz, procedimentos alternativos foram usados com sucesso para análise de amostras lipêmicas e hemolisadas de plasmas. Sendo assim, este é o primeiro método bioanalítico desenvolvido, rápido e confiável, para quantificar os enantiômeros da FLV em amostras de plasma por EKC usando a SLE como técnica de preparo de amostra. / Nowadays, cardiovascular diseases are the main causes of death in Brazil and worldwide. Statins are considered the most effective and well tolerated agents for the excessive increase in cholesterol blood levels, or hypercholesterolemia. Fluvastatin (FLV), a hypolipidemic second generation drug belongs to statin drug class, and it is commercialized as a racemate, that is, a equimolar mixture of (+)-3R, 5S- FLV and (-)-3S, 5R- FLV. Moreover, literature describes that (+)-3R, 5S- FLV enantiomer activity is thirty times higher than its antipode, which justifies the importance and necessity of methods for the stereoselective analysis of drugs which possess one or more than one asymmetry centers. Thus, this work aims the extraction of FLV enantiomers from a biological matrix (plasma) using one of the electromigration techniques, the EKC. FLV analysis by EKC employed large volume sample stacking as sample on-column concentration technique using a fused-silica capillary with 50.0 cm effective length and 75 ?m internal diameter, 50 mmol L-1 sodium tetraborate buffer, pH 9,5 plus 20 mmol L-1 2-hydroxipropyl-?-cyclodextrin as a background electrolyte, voltage of +25 kV, temperature of 15ºC, with sample injected in hydrodynamic injection mode (0,5 psi for 30 seconds) and detection using a diode array detector set at 300 nm. The enantiomers resolution was achieved with a resolution value of 3.0, and efficiency of 255840 and 150056, migration times of 7.2 and 7.4 minutes for (+)-3R, 5S- FLV and (-)-3S, 5R- FLV, respectively. Supported liquid extraction was the chosen sample preparation procedure, with the addition of 0.5 mL of 0.1 mol L-1 pH 7.0 phosphate buffer to 0.5 mL of plasma, the mixture was applied to the column and allowed to wet for 15 minutes, 4 mL of ethyl ether was then applied to the top of the column, allowed to percolate by gravity and the eluted solvent was collected in an ambar tube, the solvent was submitted to evaporation under nitrogen flow and the residue was ressuspended for injection in the capillary electrophoresis equipment. The analytical method was validated covering selectivity, linearity, within-run and between-run precision and accuracy, limit of quantification, carry-over, matrix effect, dilution integrity and stability studies parameters. The racemization study was also performed. The results support that the analytical method is linear in the range of concentrations from 250 to 725 ng mL-1for each enantiomer, and the limit of quantification was 250 ng mL-1; the method is precise and accurate, with variation under 15%. Besides, no carry-over effect was observed, and both enantiomers showed to be stable under thaw and freeze cycles, short and long term stability studies, autosampler stability, and also no racemization was observed. Related to matrix effect, alternative procedures were employed sucessfully in case of analysis of lipemeic and hemolized matrices. So, this is the first bioanalytical method developed, fast and reliable, to quantify FLV enantiomers in plasma samples using EKC with SLE as sample preparation procedure.

This thesis is about excitation, detection, properties and applications of multiple quantum coherences applied to different dipolar coupled spin systems. Major focus of the work is on spectral simplification, measurement of residual dipolar couplings and discrimination of enantiomers in chiral aligning media. The first chapter gives a brief account on the fundamentals of nuclear magnetic resonance spectroscopy and multiple quantum coherences. This includes a description of product operator and polarization operator formalisms of pulses and evolution of magnetization. Subsequently a detailed account of two dimensional multiple quantum – single quantum (MQ-SQ) correlation experiments is given. Demonstration of the homonuclear MQ-SQ pulse sequence on a weakly coupled spin system and analysis of the spectrum obtained are also discussed. Homo-nuclear multiple quantum studies carried out to obtain relative the signs of the couplings have been reported in the initial part of the second chapter. The technique has been applied on doubly labeled acetonitrile (13CH313C15N) aligned in a liquid crystalline medium. Special situations like ambiguity in the determination of relative signs of the couplings from the appearance of two dimensional MQ-SQ spectra and the explanation for the same are also discussed. Homo-nuclear MQ experiments on indistinguishable spins, like protons in a methyl group of 13CH313C15N oriented in liquid crystal, and distinguishable spins, like the two carbons in the same molecule, have been carried out. Different directions of approach in which these results need to be analyzed have been discussed. Subsequent part of the chapter is about the correlation of connected MQ-SQ coherences. These experiments are significant in reducing the cross-peaks further from the MQ-SQ spectra. This concept is extended for the discrimination of optical enantiomers dissolved in chiral aligning medium made of poly-Γ-benzyl-L-glutamate (PBLG) and CDCl3. In molecules of Chemical and biological interest one encounters several nuclei such as, 1H, 13C, 15N and 19F. It will be of general interest to determine magnitudes and relative signs of the couplings among these coupled nuclei by NMR experiments. Utilization of hetero-nuclear MQ Experiments in solving such problems is discussed in the third Chapter. Hetero-nuclear MQ experiments were carried out on dipolar coupled 13CH313C15N, with the aim of obtaining the values and signs of various hetero-nuclear couplings in the molecule. The splitting of transitions in the spectra of oriented molecules is always influenced by the sum of dipolar and scalar couplings. Hence precise determination of dipolar couplings requires the knowledge of scalar couplings. To determine the J couplings, experiments were carried out on the same molecule in isotropic medium. When many coupled nuclei are involved one has to carry out several experiments to derive all the spectral parameters. In circumventing this problem heteronuclear multiple quantum experiments involving more than two nuclei as active spins are advantageous. This reduces the number of experiments and thereby reducing the total experimental time. Second part of this chapter demonstrates how a triple resonance triple quantum experiment can provide majority of the couplings from a given coupled system. The feasibility of the experiment is demonstrated even for molecules containing natural abundant isotopes. Application of multiple quantum j-resolved technique for chiral discrimination and obtaining complete one dimensional spectrum of each enantiomer from their racemic mixture is discussed in the fourth chapter. The two dimensional experiment consists of a selective double quantum excitation period followed by selective refocusing during indirect time domain, isotropic mixing and nonselective detection of SQ transitions. Hence this pulse sequence is named as DQSERF-COSY (Double Quantum Selective Refocused Correlation Spectroscopy). The experiment exploits the existence of different intra-methyl couplings between the enantiomers dissolved in chiral liquid crystal medium to separate the one dimensional spectra of each enantiomer in different cross sections. This is possible due to the fact that all the nuclei in any one of the enantiomers are coupled among themselves and there is no inter molecular interaction between the two enantiomers. Also one can extract all the couplings between protons in each enantiomer, which can subsequently be utilized for determination of the residual dipolar couplings, structure and orientation parameters.

Atualmente, as doenças cardiovasculares constituem as principais causas de morte no Brasil e no mundo. As estatinas são consideradas os agentes mais efetivos e mais bem tolerados para o tratamento do aumento excessivo dos níveis de colesterol no sangue, ou hipercolesterolemia. A fluvastatina (FLV), um fármaco hipolipêmico, de segunda geração, pertencente à classe das estatinas, e é comercializada como mistura racêmica, ou seja, uma mistura equimolar da (+)-3R, 5S-FLV e (-)-3S, 5R-FLV. Além disso, é descrito na literatura que o enantiômero (+)- 3R, 5S- FLV possui atividade cerca de trinta vezes maior do que seu antípoda, o que justifica a importância e necessidade de métodos para análise enantiosseletiva de fármacos que possuam um ou mais centros de assimetria. Assim, este trabalho teve como objetivo a extração dos enantiômeros da FLV de matriz biológica (plasma) utilizando uma técnica de eletromigração em capilar, a cromatografia eletrocinética (EKC). A análise da FLV por cromatografia eletrocinética empregou como técnica de concentração online o stacking por injeção de grande volume, em um capilar de sílica fundida não revestido, de 50,0 cm de comprimento efetivo e 75 ?m de diâmetro interno, solução tampão tetraborato de sódio 50 mmol L-1, pH 9,5; adicionado de 20 mmol L-1 de 2-hidroxipropil-?-ciclodextrina como eletrólito de corrida, tensão de +25 kV, temperatura de 15 °C, injeção hidrodinâmica (0,5 psi por 30 segundos) e detecção em 300 nm. A separação dos enantiômeros foi obtida com valores de resolução de 3,0 e eficiência de 255840 e 150056, e tempos de migração de 7,2 e 7,4 minutos para a (+)-3R, 5S- FLV e (-)-3S, 5R- FLV, respectivamente. O procedimento de preparo de amostra foi baseado na extração em fase sólido-líquida (SLE), com a adição de 0,5 mL de solução tampão fosfato de sódio 0,1 mol L-1 pH 7,0 em 0,5 mL de plasma, previamente fortificado com padrão de FLV. A amostra foi aplicada na coluna e depois de 15 minutos, a FLV foi eluída com 4 mL de éter etílico. O método analítico foi validado avaliando os parâmetros seletividade, linearidade, precisão e exatidão inter e intra-dia, limite de quantificação, carry-over, efeito matriz, integridade da diluição e estudos de estabilidade. Além disso, foi realizado o estudo de racemização. Os resultados apresentaram linearidade na faixa de concentração plasmática de 250 a 725 ng mL-1 para cada enantiômero, sendo o limite de quantificação a concentração de 250 ng mL-1. Os estudos de precisão e exatidão apresentaram valores aceitáveis, com variação menor do que 15%. Além disso, não foi observado efeito carry-over e as amostras foram estáveis quando submetidas a ciclos de congelamento e descongelamento, estabilidade de curta e longa duração, pós-processamento e não foi observada racemização dos enantiômeros. Em relação ao efeito matriz, procedimentos alternativos foram usados com sucesso para análise de amostras lipêmicas e hemolisadas de plasmas. Sendo assim, este é o primeiro método bioanalítico desenvolvido, rápido e confiável, para quantificar os enantiômeros da FLV em amostras de plasma por EKC usando a SLE como técnica de preparo de amostra. / Nowadays, cardiovascular diseases are the main causes of death in Brazil and worldwide. Statins are considered the most effective and well tolerated agents for the excessive increase in cholesterol blood levels, or hypercholesterolemia. Fluvastatin (FLV), a hypolipidemic second generation drug belongs to statin drug class, and it is commercialized as a racemate, that is, a equimolar mixture of (+)-3R, 5S- FLV and (-)-3S, 5R- FLV. Moreover, literature describes that (+)-3R, 5S- FLV enantiomer activity is thirty times higher than its antipode, which justifies the importance and necessity of methods for the stereoselective analysis of drugs which possess one or more than one asymmetry centers. Thus, this work aims the extraction of FLV enantiomers from a biological matrix (plasma) using one of the electromigration techniques, the EKC. FLV analysis by EKC employed large volume sample stacking as sample on-column concentration technique using a fused-silica capillary with 50.0 cm effective length and 75 ?m internal diameter, 50 mmol L-1 sodium tetraborate buffer, pH 9,5 plus 20 mmol L-1 2-hydroxipropyl-?-cyclodextrin as a background electrolyte, voltage of +25 kV, temperature of 15ºC, with sample injected in hydrodynamic injection mode (0,5 psi for 30 seconds) and detection using a diode array detector set at 300 nm. The enantiomers resolution was achieved with a resolution value of 3.0, and efficiency of 255840 and 150056, migration times of 7.2 and 7.4 minutes for (+)-3R, 5S- FLV and (-)-3S, 5R- FLV, respectively. Supported liquid extraction was the chosen sample preparation procedure, with the addition of 0.5 mL of 0.1 mol L-1 pH 7.0 phosphate buffer to 0.5 mL of plasma, the mixture was applied to the column and allowed to wet for 15 minutes, 4 mL of ethyl ether was then applied to the top of the column, allowed to percolate by gravity and the eluted solvent was collected in an ambar tube, the solvent was submitted to evaporation under nitrogen flow and the residue was ressuspended for injection in the capillary electrophoresis equipment. The analytical method was validated covering selectivity, linearity, within-run and between-run precision and accuracy, limit of quantification, carry-over, matrix effect, dilution integrity and stability studies parameters. The racemization study was also performed. The results support that the analytical method is linear in the range of concentrations from 250 to 725 ng mL-1for each enantiomer, and the limit of quantification was 250 ng mL-1; the method is precise and accurate, with variation under 15%. Besides, no carry-over effect was observed, and both enantiomers showed to be stable under thaw and freeze cycles, short and long term stability studies, autosampler stability, and also no racemization was observed. Related to matrix effect, alternative procedures were employed sucessfully in case of analysis of lipemeic and hemolized matrices. So, this is the first bioanalytical method developed, fast and reliable, to quantify FLV enantiomers in plasma samples using EKC with SLE as sample preparation procedure.

La chromatographie en phase liquide bidimensionnelle est une technique à fort potentiel, offrant un grand pouvoir de séparation. Après avoir démontré son intérêt dans l’industrie pharmaceutique et présenté les enjeux liés à l’analyse quantitative, une attention particulière est portée sur le développement de méthodes. Dans l’idée de développer une stratégie d’analyse générique, la première étape est de sélectionner un set de trois systèmes 2D par le biais d’une approche développée au laboratoire. La deuxième étape est d’évaluer le potentiel de ces systèmes pour l’analyse quantitative. Ces deux étapes ont conduit à la proposition d’une stratégie d’analyse applicable à l’analyse pharmaceutique dans un contexte industriel. Enfin le potentiel du couplage RPLCxSFC est envisagé dans deux cas de figure différents. Premièrement, dans le but de comparer ce couplage aux séparations RPLCxRPLC développées dans le cadre d’une stratégie analytique générique, en termes de pouvoir de séparation. Deuxièmement, dans le cadre de l’analyse de composés chiraux, en développant un couplage sRPLCxSFC permettant une analyse achirale/chirale simultanée. Les avantages d’une telle approche ont été mis en avant en la comparant aux approches conventionnelles / Two-dimensional liquid chromatography (2D-LC) is a powerful technique considering its high separation power. After showing the advantage of 2D-LC in the pharmaceutical area and presenting the challenges related to quantitative analysis, special attention was paid to method development. With the aim of developing a generic analytical strategy for pharmaceuticals, the first step of our approach consisted in selecting a set of three 2D-systems with the help of a methodology previously developed. In a second step, the potential of these 2D-systems was evaluated for the purpose of quantitative analysis. An analytical strategy able to be applied to pharmaceutical analysis in an industrial context was proposed. Finally, the potential of RPLCxSFC was investigated in two different cases. Firstly, for comparing this on-line two dimensional technique to on-line RPLCxRPLC with respect of the separation power. Secondly, for chiral compounds by developing a selective RPLCxSFC method for simultaneous achiral-chiral analysis. The advantage of such method was highlighted by comparing to conventional approaches

Separation technologies have occupied a central role in the current practices of analytical methods used for drug analysis today. As the emphasis in contemporary drug analysis shifts towards ultra-trace concentrations, the contribution from unwanted matrix interferences takes on greater significance. In order to single out a trace substance with confidence from a rapidly expanding list of drug compounds (and their metabolites) in real complex specimens, analytical technologies must evolve to keep up with such trends. Today, the task of unambiguous identification in forensic toxicology still relies heavily upon chromatographic methods based on mass spectrometric detection, in particular GC-MS in electron ionisation (EI) mode. Although the combined informing power of (EI) GC-MS has served faithfully in a myriad of drug application studies to date, we may ask if (EI) GC-MS will remain competitive in meeting the impending needs of ultra-trace drug analysis in the fut ure? To what extent of reliability can sample clean-up strategies be used in ultra-trace analysis without risking the loss of important analytes of interest? The increasing use of tandem mass spectrometry with one-dimensional (1D) chromatographic techniques (e.g. GC-MS/MS) at its simplest, considers that single-column chromatographic analysis with mass spectrometry alone is not sufficient in providing unambiguous confirmation of the identity of any given peak, particularly when there are peak-overlap. Where the mass spectra of the individual overlapping peaks are highly similar, confounding interpretation of their identities may arise. By introducing an additional resolution element in the chromatographic domain of a 1D chromatographic system, the informing power of the analytical system can also be effectively raised by the boost in resolving power from two chromatographic elements. Thus this thesis sets out to address the analytical challenges of modern drug analysis through the application of high resolut ion comprehensive two-dimensional gas chromatography (GC„eGC) to a series of representative drug studies of relevance to forensic sciences.